Drop in Hormone Therapy Leads to Cancer Decline
A decrease in hormone use by women has led to a decline in breast cancer cases, according to new research published in the New England Journal of Medicine this week.
On NPR's All Things Considered, host Michele Norris discusses this research with Deborah Grady, MD, MPH, who notes that while there are alternatives to hormone replacement therapy, there are not a lot of good choices for women with severe menopausal symptoms.
Grady is professor of epidemiology and biostatistics and of medicine, vice chair of the Department of Epidemiology, co-director of the UCSF Clinical and Translational Science Institute (CTSI), and director of the UCSF Women's Health Clinical Research Center.
Related Links:
Drop in Hormone Therapy Leads to Cancer Decline
All Things Considered, NPR, April 19, 2007
The Faces of UCSF: Deborah Grady
advancing health worldwide™
|
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Donald A. Berry, et alia
New England Journal of Medicine356:1670-1674, April 19, 2007
Abstract |
Full Text | Full
Text (PDF) |
Drop in Hormone Therapy Leads to Cancer Decline
All Things Considered, NPR, April 19, 2007
The Faces of UCSF: Deborah Grady
advancing health worldwide™